Clene Inc.
NASDAQ:CLNN

Watchlist Manager
Clene Inc. Logo
Clene Inc.
NASDAQ:CLNN
Watchlist
Price: 6.68 USD 10.6% Market Closed
Market Cap: 69m USD

Wall Street
Price Targets

CLNN Price Targets Summary
Clene Inc.

Wall Street analysts forecast CLNN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLNN is 32.49 USD with a low forecast of 23.23 USD and a high forecast of 50.4 USD.

Lowest
Price Target
23.23 USD
248% Upside
Average
Price Target
32.49 USD
386% Upside
Highest
Price Target
50.4 USD
654% Upside
Clene Inc. Competitors:
Price Targets
BBIO
BridgeBio Pharma Inc
12% Upside
TGTX
TG Therapeutics Inc
46% Upside
206650
EuBiologics Co Ltd
60% Upside
PEB
Pacific Edge Ltd
23% Downside
688235
Beigene Ltd
35% Upside
688105
Nanjing Vazyme Biotech Co Ltd
43% Upside
CUV
Clinuvel Pharmaceuticals Ltd
98% Upside
GILD
Gilead Sciences Inc
9% Upside

Revenue
Forecast

Revenue Estimate
Clene Inc.

The compound annual growth rate of Clene Inc.'s revenue for the next 4 years is 351%.

N/A
Past Growth
351%
Estimated Growth
Estimates Accuracy
15%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Clene Inc.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Clene Inc.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-75%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CLNN's stock price target?
Price Target
32.49 USD

According to Wall Street analysts, the average 1-year price target for CLNN is 32.49 USD with a low forecast of 23.23 USD and a high forecast of 50.4 USD.

What is Clene Inc.'s Revenue forecast?
Projected CAGR
351%

The compound annual growth rate of Clene Inc.'s revenue for the next 4 years is 351%.

Back to Top